Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment
Open Access
- 15 July 2021
- journal article
- research article
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 15 (4), 606-615
- https://doi.org/10.5009/gnl20267
Abstract
Jeong Eun Song, Min Kyu Kang, Yu Rim Lee, Chang Hyeong Lee, Jung Gil Park, Young Oh Kweon, Won Young Tak, Soo Young Park, Se Young Jang, Jae Seok Hwang, Byoung Kuk Jang, Won Young Jang, Jeong Ill Suh, Woo Jin Chung, and Byung Seok Kim, Daegu-Gyeongbuk Liver Study Group (DGLSG). Gut and Liver 2021;15:606-15. https://doi.org/10.5009/gnl20267Keywords
This publication has 36 references indexed in Scilit:
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Characteristics of COVID-19 infection in BeijingJournal of Infection, 2020
- [Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia].2020
- Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV InfectionPublished by Cold Spring Harbor Laboratory ,2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Hepatobiliary Complications in Critically Ill PatientsClinics in Liver Disease, 2019
- Serum alanine aminotransferase level and liver‐related mortality in patients with chronic hepatitis B: A large national cohort studyLiver International, 2018
- Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral ActivitiesJournal of Medicinal Chemistry, 2006
- Lung alkaline phosphatase as a marker of fibrosis in chronic interstitial disorders.American Journal of Respiratory and Critical Care Medicine, 1997